Literature DB >> 26842900

[Lumbar back pain in patients with Parkinson's disease].

O Rommel1, D Wejwer2, K Schybek2, T Przybilski3, G Jäger3, S Gräber4, D Berg4.   

Abstract

BACKGROUND: Lumbar back pain is a frequent symptom in patients with advanced Parkinson's disease. We examined the effect of modification of the dopaminergic medication, x-ray-controlled lumbar spine injections and analgesics combined with physiotherapy.
METHODS: The data from 50 patients with Parkinson's disease and lumbar back pain were retrospectively analyzed. A structured L-dopa test was performed with all patients, whereby the pain intensity and mobility were monitored before and after the administration of L-dopa. Dopaminergic medication was adjusted in patients who reported either a reduction in pain intensity (> 20%) and/or an improvement of measured mobility and X-ray controlled lumbar spine injections were conducted in patients who reported persistent pain. Analgesics were introduced or dosages were raised in patients who had already received lumbar spine injections and continued to report pain. All patients participated in a daily physiotherapy program.
RESULTS: In the L-dopa test an improvement of mobility could be demonstrated in 40 patients and reduced pain intensity in 21 patients. In 37 patients with a positive L-dopa test the dopaminergic medication was adjusted. In 12 of these patients (24%) a decrease of pain intensity could be observed. Due to persisting back pain in 30 patients lumbar spine injections were conducted. Of these patients 17 (34%) had pain improvement. In 20 patients analgesics were applied and induced pain relief in 15 patients (30%). Overall 44 patients (88%) had an improvement in pain. DISCUSSION: Even in cases of severe lumbar spine pathology adjustment of dopaminergic medication should be tested in all patients with Parkinson's disease and lumbar back pain. In patients with persistent pain facet joint injections as well as analgesics may be helpful and should be tested according to the predominant pain characteristics.

Entities:  

Keywords:  Analgesics; Facet joint; L-dopa; Lumbar back pain; Spinal injections

Mesh:

Substances:

Year:  2016        PMID: 26842900     DOI: 10.1007/s00115-015-0060-2

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  23 in total

1.  [Pain in Parkinson's disease].

Authors:  R Giuffrida; F J G Vingerhoets; J Bogousslavsky; J Ghika
Journal:  Rev Neurol (Paris)       Date:  2005-04       Impact factor: 2.607

2.  Back problems in Parkinson's disease: an underestimated problem.

Authors:  Fabien Etchepare; Sylvie Rozenberg; Tristan Mirault; Anne-Marie Bonnet; Colette Lecorre; Yves Agid; Pierre Bourgeois; Bruno Fautrel
Journal:  Joint Bone Spine       Date:  2005-11-15       Impact factor: 4.929

3.  Reduction of dyskinesia and induction of akinesia induced by morphine in two parkinsonian patients with severe sciatica.

Authors:  D Berg; G Becker; K Reiners
Journal:  J Neural Transm (Vienna)       Date:  1999       Impact factor: 3.575

4.  Effects of gabapentin on the motor response to levodopa: a double-blind, placebo-controlled, crossover study in patients with complicated Parkinson disease.

Authors:  N Van Blercom; A Lasa; K Verger; X Masramón; V M Sastre; G Linazasoro
Journal:  Clin Neuropharmacol       Date:  2004 May-Jun       Impact factor: 1.592

5.  Levodopa and induced-pain response. A study of patients with Parkinsonian and pain syndromes.

Authors:  A F Battista; B B Wolff
Journal:  Arch Intern Med       Date:  1973-07

Review 6.  Osteoporosis in Parkinson's disease.

Authors:  Marco Invernizzi; Stefano Carda; Giovanni Sguazzini Viscontini; Carlo Cisari
Journal:  Parkinsonism Relat Disord       Date:  2009-04-05       Impact factor: 4.891

7.  [S3 guideline LONTS. Long-term administration of opioids for non-tumor pain].

Authors:  H Reinecke; H Sorgatz
Journal:  Schmerz       Date:  2009-10       Impact factor: 1.107

8.  Pain as a nonmotor symptom of Parkinson disease: evidence from a case-control study.

Authors:  Giovanni Defazio; Alfredo Berardelli; Giovanni Fabbrini; Davide Martino; Emiliana Fincati; Antonio Fiaschi; Giuseppe Moretto; Giovanni Abbruzzese; Roberta Marchese; Ubaldo Bonuccelli; Paolo Del Dotto; Paolo Barone; Elisa De Vivo; Alberto Albanese; Angelo Antonini; Margherita Canesi; Leonardo Lopiano; Maurizio Zibetti; Giuseppe Nappi; Emilia Martignoni; Paolo Lamberti; Michele Tinazzi
Journal:  Arch Neurol       Date:  2008-09

9.  A comparison of intraarticular lumbar facet joint steroid injections and lumbar facet joint radiofrequency denervation in the treatment of low back pain: a randomized, controlled, double-blind trial.

Authors:  Stefan Lakemeier; Marcel Lind; Wolfgang Schultz; Susanne Fuchs-Winkelmann; Nina Timmesfeld; Christian Foelsch; Christian D Peterlein
Journal:  Anesth Analg       Date:  2013-04-30       Impact factor: 5.108

10.  Pain intensity on and off levodopa in patients with Parkinson's disease.

Authors:  Angelika Nebe; Georg Ebersbach
Journal:  Mov Disord       Date:  2009-06-15       Impact factor: 10.338

View more
  1 in total

1.  The prevalence of chronic low back pain and lumbar deformities in patients with Parkinson's disease: implications on spinal surgery.

Authors:  Imke Galazky; Christina Caspari; Hans-Jochen Heinze; Joerg Franke
Journal:  Eur Spine J       Date:  2018-09-08       Impact factor: 3.134

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.